Biobanking, Gene, Genetics and Hormones - Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Biobanking

Gene

Genetics

Hormones

Alnylam finds belly fat gene and drug target in UK Biobank study

pharmaphorum

JULY 28, 2022

Alnylam Pharma has made a name for itself, developing gene-silencing therapies for rare disorders, but its latest discovery could take it into a much larger category – metabolic and cardiovascular disease. Transgenic mice in which the gene has been deleted have improved control of blood glucose and insulin sensitivity.

Biobanking

Biobanking Gene Gene Silencing Drugs

Research Roundup: Blood Test for Severe COVID-19 and More

The Pharma Data

JANUARY 21, 2021

Four years ago, the University of Malta established a national ALS Registry and Biobank to identify ALS patients and collect data on their residence, occupation, lifestyle and environmental exposures. Specifically, the Malta patients did not have mutations in the C9orf72, SOD1, TARDBP and FUS genes.

Research

Research DNA Hormones Vaccination

Alnylam finds belly fat gene and drug target in UK Biobank study

Research Roundup: Blood Test for Severe COVID-19 and More

Stay Connected